Gary Taylor
Stock Analyst at TD Cowen
(2.62)
# 2,007
Out of 5,169 analysts
148
Total ratings
51.52%
Success rate
0.63%
Average return
Main Sectors:
Stocks Rated by Gary Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Buy | $44 → $25 | $23.20 | +7.76% | 5 | Aug 7, 2025 | |
| BBWI Bath & Body Works | Maintains: Buy | $40 → $42 | $19.98 | +110.21% | 2 | Nov 26, 2024 | |
| PIII P3 Health Partners | Maintains: Hold | $45 → $13 | $2.69 | +364.68% | 2 | Nov 20, 2024 | |
| AGL agilon health | Maintains: Hold | $6 → $2 | $0.59 | +238.93% | 4 | Nov 11, 2024 | |
| HUM Humana | Maintains: Hold | $261 → $268 | $170.42 | +57.26% | 20 | Nov 4, 2024 | |
| ALHC Alignment Healthcare | Maintains: Buy | $10 → $13 | $18.19 | -28.53% | 6 | Oct 31, 2024 | |
| HCA HCA Healthcare | Maintains: Buy | $450 → $440 | $502.05 | -12.36% | 9 | Oct 28, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $601 → $609 | $284.33 | +114.19% | 4 | Oct 18, 2024 | |
| CNC Centene | Maintains: Buy | $80 → $89 | $36.16 | +146.13% | 10 | Jul 31, 2024 | |
| MOH Molina Healthcare | Maintains: Buy | $351 → $378 | $148.63 | +154.32% | 18 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $183 → $220 | $189.58 | +16.05% | 12 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $139 → $150 | $148.83 | +0.79% | 11 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $26 | $21.59 | +20.43% | 5 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $39 → $35 | $12.36 | +183.17% | 2 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $564 → $585 | $294.95 | +98.34% | 2 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $6 | $13.56 | -55.75% | 1 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $10 → $8 | $6.41 | +24.80% | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $242 → $329 | $264.61 | +24.33% | 3 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | $7 → $3 | $1.88 | +59.57% | 4 | Feb 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $17 | $8.24 | +106.31% | 1 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $28 → $20 | $203.21 | -90.16% | 12 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $20 | $19.83 | +0.86% | 6 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.04 | - | 6 | Dec 14, 2017 |
Acadia Healthcare Company
Aug 7, 2025
Maintains: Buy
Price Target: $44 → $25
Current: $23.20
Upside: +7.76%
Bath & Body Works
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $42
Current: $19.98
Upside: +110.21%
P3 Health Partners
Nov 20, 2024
Maintains: Hold
Price Target: $45 → $13
Current: $2.69
Upside: +364.68%
agilon health
Nov 11, 2024
Maintains: Hold
Price Target: $6 → $2
Current: $0.59
Upside: +238.93%
Humana
Nov 4, 2024
Maintains: Hold
Price Target: $261 → $268
Current: $170.42
Upside: +57.26%
Alignment Healthcare
Oct 31, 2024
Maintains: Buy
Price Target: $10 → $13
Current: $18.19
Upside: -28.53%
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450 → $440
Current: $502.05
Upside: -12.36%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601 → $609
Current: $284.33
Upside: +114.19%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80 → $89
Current: $36.16
Upside: +146.13%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351 → $378
Current: $148.63
Upside: +154.32%
Jul 26, 2024
Maintains: Hold
Price Target: $183 → $220
Current: $189.58
Upside: +16.05%
Jul 24, 2024
Maintains: Hold
Price Target: $139 → $150
Current: $148.83
Upside: +0.79%
Mar 1, 2024
Maintains: Outperform
Price Target: $30 → $26
Current: $21.59
Upside: +20.43%
Nov 14, 2023
Upgrades: Outperform
Price Target: $39 → $35
Current: $12.36
Upside: +183.17%
Jul 24, 2023
Maintains: Outperform
Price Target: $564 → $585
Current: $294.95
Upside: +98.34%
Feb 14, 2023
Maintains: Market Perform
Price Target: $3 → $6
Current: $13.56
Upside: -55.75%
Nov 14, 2022
Maintains: Outperform
Price Target: $10 → $8
Current: $6.41
Upside: +24.80%
May 9, 2022
Upgrades: Outperform
Price Target: $242 → $329
Current: $264.61
Upside: +24.33%
Feb 2, 2022
Upgrades: Market Perform
Price Target: $7 → $3
Current: $1.88
Upside: +59.57%
Sep 10, 2021
Initiates: Market Perform
Price Target: $17
Current: $8.24
Upside: +106.31%
Sep 21, 2020
Downgrades: Underweight
Price Target: $28 → $20
Current: $203.21
Upside: -90.16%
Feb 24, 2020
Maintains: Neutral
Price Target: $33 → $20
Current: $19.83
Upside: +0.86%
Dec 14, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.04
Upside: -